MindSite News welcomes your feedback, including comments on anything you see that needs to be corrected. We ask authors for their source materials and fact-check our articles, but inevitably there will be misunderstandings and errors. We’re committed to accurate and conscientious journalism, so our policy is to make necessary corrections quickly and transparently. 

We include corrections at the top of the story in question and include the time and date of the correction. We also list them here, on our corrections page, where you can search for them by story and date.

We have not had to retire a story due to mistakes or a faulty thesis, but in the event that a story was so riddled with errors that it was impossible to fix, MindSite News’ co-editors would make the decision to pull it off the site permanently and explain why.

To ask for a correction, please fill out the form on the Contact Us page. You can also use the form to discuss articles, send us tips for stories, or make a complaint.

This is a list of the corrections we have made to stories since we launched on website in late 2021.

§ June 23, 2023: Correction: The original version of the story reported incorrectly that Emani Davis was the youngest person to be awarded the World Children’s Prize. In fact, she and her mother were the first Americans to be honored by the World’s Children’s Prize.

§ May 2, 2023: Correction: A story in our newsletter originally used the terms stimulants and amphetamines interchangeably. It has been updated to address that error. Methylphenidate, the active ingredient in Ritalin, is a stimulant, not an amphetamine.

§ March 31, 2023: Correction: Due to an editing error, a summary appearing on the MindSite News home page and in the preview section of our emailed newsletter, used the word “fatally” to describe the shooting of Raul de la Cruz. As of the time that the newsletter was finalized and published on the MindSite News website, Mr. de la Cruz was, in fact, reported to be alive and in critical condition. MindSite News regrets the error.

§ November 11, 2021: Correction: The original version of this story A Digital Mental Health Revolution – But for Whom? reported incorrectly that the venture fund Venrock invested in Akili, Woebot and Lyra Health; in fact the company is only invested in Lyra

Cerebral CEO David Mou also wrote to say that our article also “grossly misrepresented” his company, Cerebral, as a “one-click platform for prescribing antidepressants.” Cerebral, he wrote, “provides holistic mental healthcare that includes medication management as well as counseling and/or weekly therapy. Most importantly, we have demonstrated great clinical outcomes and increased care adherence across hundreds of thousands of patients.” (The entire text of his email, which we published with permission as a Letter to the Editor, can be found here.) Update: On May 7, 2022, the Department of Justice launched a federal investigation into Cerebral, which is still ongoing, for its prescribing practices and possible violations of the Controlled Substances Act.